Tatsuki Ueda
- Oncology top 5%
- CAR-T cell therapy research 10
- Pancreatic and Hepatic Oncology Research 3
- Immunology top 10%
- Immune Cell Function and Interaction 6
-
- CRISPR and Genetic Engineering 4
- Pluripotent Stem Cells Research 3
- Viral Infectious Diseases and Gene Expression in Insects 2
-
- Gallbladder and Bile Duct Disorders 4
-
- Pediatric Hepatobiliary Diseases and Treatments 3
- Co-authors
- Shin KanekoHuaigeng XuAkitsu HottaMiyuki OnoMisato NishikawaKeisuke OkitaYoshinori YoshidaFumiyo Kitaoka
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Nature Biomedical Engineering (2 papers)Cell stem cell (2 papers)Molecular Therapy (1 paper)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Tatsuki Ueda
22 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 530
- Immunology 282
- Molecular Biology 645
- Genetics 52
- Genetics 135
Countries citing papers authored by Tatsuki Ueda
This map shows the geographic impact of Tatsuki Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuki Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuki Ueda more than expected).
Fields of papers citing papers by Tatsuki Ueda
This network shows the impact of papers produced by Tatsuki Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuki Ueda. The network helps show where Tatsuki Ueda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tatsuki Ueda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 34 | |
| 3 | 2024 | 5 | |
| 4 | 2022 | 48 | |
| 5 | 2021 | 149 | |
| 6 | 2021 | 118 | |
| 7 | 2021 | 26 | |
| 8 | 2020 | 10 | |
| 9 | CRISPR-Cas9を介するHLA遺伝子の標的化破壊は免疫適合性を増強したIPSCを生成する【JST・京大機械翻訳】 | 2019 | 71 |
| 10 | Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibilitybreakdown → | 2019 | 411 |
| 11 | 2019 | 10 | |
| 12 | 2018 | 20 | |
| 13 | 2016 | 7 | |
| 14 | 2014 | 0 | |
| 15 | 2013 | 2 | |
| 16 | 2013 | 0 | |
| 17 | 1995 | 7 | |
| 18 | [Immunohistochemical study of the coexpression of epidermal growth factor receptor (EGFR) and c-erbB-2 protein in colorectal cancer]. | 1993 | 3 |
| 19 | 1993 | 8 | |
| 20 | [Clinical evaluation of high dose intravenous injection of fosfomycin on the severe infections associated with the treatment of haematological disorders]. | 1983 | 2 |
About Tatsuki Ueda
Tatsuki Ueda is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (6 papers), CRISPR and Genetic Engineering (4 papers), Gallbladder and Bile Duct Disorders (4 papers), Pluripotent Stem Cells Research (3 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Oncology (530 citations), Immunology (282 citations) and Molecular Biology (645 citations). Tatsuki Ueda has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Shin Kaneko, Huaigeng Xu, Akitsu Hotta, Miyuki Ono, Misato Nishikawa, Keisuke Okita, Yoshinori Yoshida, Fumiyo Kitaoka, Tomoko Takahashi and Noriko Sasakawa. Their work appears in journals such as Nature Biomedical Engineering, Cell stem cell, Molecular Therapy, Nature Methods and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.